Company / Profit Margin
Aclaris Therapeutics, Inc. Profit Margin History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-829.6%
FY2025
5-year range
-1344.0% / -283.2%
FY2021-FY2025
Trend
-193.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has fluctuated over the past 9 years, ranging from -4071.5% in FY2019 to -283.2% in FY2024.
Based on SEC 10-K filings.
-829.6% in FY2025 with a 5-year CAGR of +1328.4%.
Improved from -1344.0% to -829.6% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -537.5pp
- 5-Year Change
- +1328.4pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin decreased 193.0% year-over-year.
- Peak profit margin was recorded in FY2024.
- Lowest profit margin in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -5.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -829.6% | -193.0% |
| FY2024 | -283.2% | +78.9% |
| FY2023 | -1344.0% | -360.1% |
| FY2022 | -292.1% | +78.3% |
| FY2021 | -1344.0% | +37.7% |
| FY2020 | -2158.0% | +47.0% |
| FY2019 | -4071.5% | -88.7% |
| FY2018 | -2158.0% | -76.6% |
| FY2017 | -1221.8% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026